Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 10 of 634 items for :

  • endocrine cancers x
Clear All
Bliss Anderson Department of Endocrinology, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK

Search for other papers by Bliss Anderson in
Google Scholar
PubMed Close
and
Daniel L Morganstein Department of Endocrinology, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK

Search for other papers by Daniel L Morganstein in
Google Scholar
PubMed Close

, as a result of cancer or its treatment, without endocrine dysfunction, so a thorough evaluation is required before starting hormone replacement. Long term implications Unlike most other IRAEs, endocrinopathy is usually non-reversible and is

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-20-0489
Volume/Issue:
Volume 10: Issue 3
Open access
Judith Gebauer Department of Internal Medicine I, University Hospital Schleswig-Holstein, Luebeck, Germany

Search for other papers by Judith Gebauer in
Google Scholar
PubMed Close
and
Claire E Higham Department of Endocrinology, Christie Hospital NHS Foundation Trust, University of Manchester, and Manchester Academic Health Science Centre, Manchester, UK

Search for other papers by Claire E Higham in
Google Scholar
PubMed Close

to care ( 7 ). Up to half of them will develop endocrine or metabolic consequences. Figure 1 Relative risks for chronic health conditions in childhood cancer survivors (compared to their siblings) ( 9 ). Childhood cancer survivors

Article Type:
Editorial
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-22-0261
Volume/Issue:
Volume 11: Issue 9
Open access
Mahmoud Al-Masri Department of Surgery, King Hussein Cancer Center, Amman, Jordan

Search for other papers by Mahmoud Al-Masri in
Google Scholar
PubMed Close
,
Tawfiq Al-Shobaki Department of Surgery, King Hussein Cancer Center, Amman, Jordan

Search for other papers by Tawfiq Al-Shobaki in
Google Scholar
PubMed Close
,
Hani Al-Najjar Department of Surgery, King Hussein Cancer Center, Amman, Jordan

Search for other papers by Hani Al-Najjar in
Google Scholar
PubMed Close
,
Rafal Iskanderian Department of Surgery, King Hussein Cancer Center, Amman, Jordan

Search for other papers by Rafal Iskanderian in
Google Scholar
PubMed Close
,
Enas Younis Department of Internal Medicine, Endocrine, King Hussein Cancer Center, Amman, Jordan

Search for other papers by Enas Younis in
Google Scholar
PubMed Close
,
Niveen Abdallah Department of Cell Therapy & Applied Genomics, King Hussein Cancer Center, Amman, Jordan

Search for other papers by Niveen Abdallah in
Google Scholar
PubMed Close
,
Abdelghani Tbakhi Department of Cell Therapy & Applied Genomics, King Hussein Cancer Center, Amman, Jordan

Search for other papers by Abdelghani Tbakhi in
Google Scholar
PubMed Close
,
Hussam Haddad Department of Pathology & Laboratory Medicine, King Hussein Cancer Center, Amman, Jordan

Search for other papers by Hussam Haddad in
Google Scholar
PubMed Close
,
Mohammad Al-Masri School of Medicine, University of Jordan, Amman, Jordan

Search for other papers by Mohammad Al-Masri in
Google Scholar
PubMed Close
,
Zeinab Obeid Department of Surgery, King Hussein Cancer Center, Amman, Jordan

Search for other papers by Zeinab Obeid in
Google Scholar
PubMed Close
, and
Awad Jarrar Department of Surgery, King Hussein Cancer Center, Amman, Jordan

Search for other papers by Awad Jarrar in
Google Scholar
PubMed Close

thyroid cancer . Endocrine Related Cancer 2005 12 245 – 262 . ( https://doi.org/10.1677/erc.1.0978 ) 14 Lin KL Wang OC Zhang XH Dai XX Hu XQ Qu JM . The BRAF mutation is predictive of aggressive clinicopathological characteristics in

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-21-0410
Volume/Issue:
Volume 10: Issue 12
Open access
K G Samsom Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands

Search for other papers by K G Samsom in
Google Scholar
PubMed Close
,
L M van Veenendaal Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands

Search for other papers by L M van Veenendaal in
Google Scholar
PubMed Close
,
G D Valk Department of Endocrine Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands

Search for other papers by G D Valk in
Google Scholar
PubMed Close
,
M R Vriens Department of Surgical Oncology and Endocrine Surgery, University Medical Centre Utrecht, Utrecht, The Netherlands

Search for other papers by M R Vriens in
Google Scholar
PubMed Close
,
M E T Tesselaar Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands

Search for other papers by M E T Tesselaar in
Google Scholar
PubMed Close
, and
J G van den Berg Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands

Search for other papers by J G van den Berg in
Google Scholar
PubMed Close

Malandrino P Ramundo V Faggiano A Colao A & NIKE Group . Predictive factors of response to mTOR inhibitors in neuroendocrine tumours . Endocrine-Related Cancer 2016 23 R173 – R183 . ( https://doi.org/10.1530/ERC-15-0413 ) 10.1530/ERC-15

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0206
Volume/Issue:
Volume 8: Issue 7
Open access
Mark J C van Treijen Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute, University Medical Center Utrecht, Utrecht, The Netherlands

Search for other papers by Mark J C van Treijen in
Google Scholar
PubMed Close
,
Catharina M Korse Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute, University Medical Center Utrecht, Utrecht, The Netherlands
Department of Clinical Chemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands

Search for other papers by Catharina M Korse in
Google Scholar
PubMed Close
,
Wieke H Verbeek Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute, University Medical Center Utrecht, Utrecht, The Netherlands
Department of Gastroenterology, The Netherlands Cancer Institute, Amsterdam, The Netherlands

Search for other papers by Wieke H Verbeek in
Google Scholar
PubMed Close
,
Margot E T Tesselaar Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute, University Medical Center Utrecht, Utrecht, The Netherlands
Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands

Search for other papers by Margot E T Tesselaar in
Google Scholar
PubMed Close
, and
Gerlof D Valk Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute, University Medical Center Utrecht, Utrecht, The Netherlands

Search for other papers by Gerlof D Valk in
Google Scholar
PubMed Close

GD & Knowledge NETwork . Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature . Endocrine-Related Cancer 2014 21 R153 – R163 . ( https://doi.org/10.1530/ERC-13-0125 ) 2 Dasari A Shen C Halperin

Article Type:
Research Article
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-22-0146
Volume/Issue:
Volume 11: Issue 10
Open access
Irfan Vardarli Department of Medicine I, Klinikum Vest, Knappschaftskrankenhaus Recklinghausen, Academic Teaching Hospital, Ruhr-University Bochum, Recklinghausen, Germany

Search for other papers by Irfan Vardarli in
Google Scholar
PubMed Close
,
Manuel Weber Department of Nuclear Medicine, University Hospital Essen, Essen, Germany

Search for other papers by Manuel Weber in
Google Scholar
PubMed Close
,
Frank Weidemann Department of Medicine I, Klinikum Vest, Knappschaftskrankenhaus Recklinghausen, Academic Teaching Hospital, Ruhr-University Bochum, Recklinghausen, Germany

Search for other papers by Frank Weidemann in
Google Scholar
PubMed Close
,
Dagmar Führer Department of Endocrinology, Diabetes and Metabolism, Clinical Chemistry – Division of Laboratory Research; Endocrine Tumor Center at WTZ/Comprehensive Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany

Search for other papers by Dagmar Führer in
Google Scholar
PubMed Close
,
Ken Herrmann Department of Nuclear Medicine, University Hospital Essen, Essen, Germany

Search for other papers by Ken Herrmann in
Google Scholar
PubMed Close
, and
Rainer Görges Department of Nuclear Medicine, University Hospital Essen, Essen, Germany

Search for other papers by Rainer Görges in
Google Scholar
PubMed Close

. Endocrine-Related Cancer 2012 19 345 – 349 . ( https://doi.org/10.1530/ERC-12-0013 ) 46 Schneider C Kobe C Schmidt M Kahraman D Malchau G Faust M Schicha H Dietlein M Calcitonin screening in patients with thyroid nodules. Diagnostic

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-21-0030
Volume/Issue:
Volume 10: Issue 3
Open access
Aleksandra Kukulska Nuclear Medicine and Endocrine Oncology Department, M. Sklodowska-Curie Institute – Oncology Center, Gliwice Branch, Gliwice, Poland
Radiotherapy Department, M. Sklodowska-Curie Institute – Oncology Center, Gliwice Branch, Gliwice, Poland

Search for other papers by Aleksandra Kukulska in
Google Scholar
PubMed Close
,
Jolanta Krajewska Nuclear Medicine and Endocrine Oncology Department, M. Sklodowska-Curie Institute – Oncology Center, Gliwice Branch, Gliwice, Poland

Search for other papers by Jolanta Krajewska in
Google Scholar
PubMed Close
,
Zofia Kolosza Department of Epidemiology and Silesia Cancer Registry, M. Sklodowska-Curie Institute – Oncology Center, Gliwice Branch, Gliwice, Poland

Search for other papers by Zofia Kolosza in
Google Scholar
PubMed Close
,
Ewa Paliczka-Cieslik Nuclear Medicine and Endocrine Oncology Department, M. Sklodowska-Curie Institute – Oncology Center, Gliwice Branch, Gliwice, Poland

Search for other papers by Ewa Paliczka-Cieslik in
Google Scholar
PubMed Close
,
Aleksandra Kropinska Nuclear Medicine and Endocrine Oncology Department, M. Sklodowska-Curie Institute – Oncology Center, Gliwice Branch, Gliwice, Poland

Search for other papers by Aleksandra Kropinska in
Google Scholar
PubMed Close
,
Agnieszka Pawlaczek Nuclear Medicine and Endocrine Oncology Department, M. Sklodowska-Curie Institute – Oncology Center, Gliwice Branch, Gliwice, Poland

Search for other papers by Agnieszka Pawlaczek in
Google Scholar
PubMed Close
,
Zbigniew Puch Nuclear Medicine and Endocrine Oncology Department, M. Sklodowska-Curie Institute – Oncology Center, Gliwice Branch, Gliwice, Poland

Search for other papers by Zbigniew Puch in
Google Scholar
PubMed Close
,
Kornelia Ficek Radiotherapy Department, M. Sklodowska-Curie Institute – Oncology Center, Gliwice Branch, Gliwice, Poland

Search for other papers by Kornelia Ficek in
Google Scholar
PubMed Close
,
Teresa Lisik Radiotherapy Department, M. Sklodowska-Curie Institute – Oncology Center, Gliwice Branch, Gliwice, Poland

Search for other papers by Teresa Lisik in
Google Scholar
PubMed Close
,
Dorota Sygula Radiotherapy Department, M. Sklodowska-Curie Institute – Oncology Center, Gliwice Branch, Gliwice, Poland

Search for other papers by Dorota Sygula in
Google Scholar
PubMed Close
,
Zbigniew Wygoda Nuclear Medicine and Endocrine Oncology Department, M. Sklodowska-Curie Institute – Oncology Center, Gliwice Branch, Gliwice, Poland

Search for other papers by Zbigniew Wygoda in
Google Scholar
PubMed Close
,
Jozef Roskosz Nuclear Medicine and Endocrine Oncology Department, M. Sklodowska-Curie Institute – Oncology Center, Gliwice Branch, Gliwice, Poland

Search for other papers by Jozef Roskosz in
Google Scholar
PubMed Close
,
Jerzy Wydmanski Radiotherapy Department, M. Sklodowska-Curie Institute – Oncology Center, Gliwice Branch, Gliwice, Poland

Search for other papers by Jerzy Wydmanski in
Google Scholar
PubMed Close
, and
Barbara Jarzab Nuclear Medicine and Endocrine Oncology Department, M. Sklodowska-Curie Institute – Oncology Center, Gliwice Branch, Gliwice, Poland

Search for other papers by Barbara Jarzab in
Google Scholar
PubMed Close

Introduction Medullary thyroid carcinoma (MTC) is a rarely diagnosed malignant neoplasm arising from C cells and constitutes only 5% of all thyroid cancers. MTC may occur as a sporadic disease or as part of hereditary multiple endocrine

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0387
Volume/Issue:
Volume 9: Issue 1
Open access
Anna Malczewska Department of Endocrinology and Neuroendocrine Tumors, Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland

Search for other papers by Anna Malczewska in
Google Scholar
PubMed Close
,
Magdalena Witkowska Department of Endocrinology and Neuroendocrine Tumors, Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland

Search for other papers by Magdalena Witkowska in
Google Scholar
PubMed Close
,
Karolina Makulik Department of Endocrinology and Neuroendocrine Tumors, Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland

Search for other papers by Karolina Makulik in
Google Scholar
PubMed Close
,
Agnes Bocian Department of Endocrinology and Neuroendocrine Tumors, Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland

Search for other papers by Agnes Bocian in
Google Scholar
PubMed Close
,
Agata Walter Department of Endocrinology and Neuroendocrine Tumors, Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland

Search for other papers by Agata Walter in
Google Scholar
PubMed Close
,
Joanna Pilch-Kowalczyk Department of Radiology and Nuclear Medicine, Medical University of Silesia, Katowice, Poland

Search for other papers by Joanna Pilch-Kowalczyk in
Google Scholar
PubMed Close
,
Wojciech Zajęcki Department of Pathology in Zabrze, Medical University of Silesia, Katowice, Poland

Search for other papers by Wojciech Zajęcki in
Google Scholar
PubMed Close
,
Lisa Bodei Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Search for other papers by Lisa Bodei in
Google Scholar
PubMed Close
,
Kjell Oberg Department of Endocrine Oncology, University Hospital, Uppsala, Sweden

Search for other papers by Kjell Oberg in
Google Scholar
PubMed Close
, and
Beata Kos-Kudła Department of Endocrinology and Neuroendocrine Tumors, Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland

Search for other papers by Beata Kos-Kudła in
Google Scholar
PubMed Close

Scoazec JY Lassau N Lebtahi R Brixi H Mitry E Guimbaud R Courbon F , et al . Evaluating digestive neuroendocrine tumor progression and therapeutic responses in the era of targeted therapies: state of the art . Endocrine-Related Cancer 2014 21 R105

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0030
Volume/Issue:
Volume 8: Issue 4
Open access
Catherine Cardot Bauters CHU Lille, Service d’Endocrinologie, Diabétologie, Métabolisme-Nutrition, Hôpital Claude Huriez, Lille, France

Search for other papers by Catherine Cardot Bauters in
Google Scholar
PubMed Close
,
Emmanuelle Leteurtre Univ. Lille, Inserm, CHU Lille, UMR-S 1277-CANTHER, Cancer Heterogeneity, Plasticity & Resistance to Therapies, Lille, France

Search for other papers by Emmanuelle Leteurtre in
Google Scholar
PubMed Close
,
Bruno Carnaille CHU Lille, Service de Chirurgie Endocrine, Hôpital Claude Huriez, Lille, France

Search for other papers by Bruno Carnaille in
Google Scholar
PubMed Close
,
Christine Do Cao CHU Lille, Service d’Endocrinologie, Diabétologie, Métabolisme-Nutrition, Hôpital Claude Huriez, Lille, France

Search for other papers by Christine Do Cao in
Google Scholar
PubMed Close
,
Stéphanie Espiard CHU Lille, Service d’Endocrinologie, Diabétologie, Métabolisme-Nutrition, Hôpital Claude Huriez, Lille, France

Search for other papers by Stéphanie Espiard in
Google Scholar
PubMed Close
,
Malo Penven CHU Lille, Service de Biochimie Hormonologie, Métabolisme, Nutrition-Oncologie, Centre de Biologie Pathologie Génétique, Lille, France

Search for other papers by Malo Penven in
Google Scholar
PubMed Close
,
Evelyne Destailleur CHU Lille, Service de Biochimie Hormonologie, Métabolisme, Nutrition-Oncologie, Centre de Biologie Pathologie Génétique, Lille, France

Search for other papers by Evelyne Destailleur in
Google Scholar
PubMed Close
,
Isabelle Szuster CHU Lille, Service de Biochimie Hormonologie, Métabolisme, Nutrition-Oncologie, Centre de Biologie Pathologie Génétique, Lille, France

Search for other papers by Isabelle Szuster in
Google Scholar
PubMed Close
,
Tonio Lovecchio CHU Lille, Service de Biochimie Hormonologie, Métabolisme, Nutrition-Oncologie, Centre de Biologie Pathologie Génétique, Lille, France

Search for other papers by Tonio Lovecchio in
Google Scholar
PubMed Close
,
Julie Leclerc Univ. Lille, Inserm, CHU Lille, UMR-S 1277-CANTHER, Cancer Heterogeneity, Plasticity & Resistance to Therapies, Lille, France
CHU Lille, Service de Biochimie Hormonologie, Métabolisme, Nutrition-Oncologie, Centre de Biologie Pathologie Génétique, Lille, France

Search for other papers by Julie Leclerc in
Google Scholar
PubMed Close
,
Fredéric Frénois Univ. Lille, CHU Lille, EA-7364 RADEME, Faculté de Médecine, Lille, France

Search for other papers by Fredéric Frénois in
Google Scholar
PubMed Close
,
Emmanuel Esquivel Dept Medicine, Mays Cancer Center, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA

Search for other papers by Emmanuel Esquivel in
Google Scholar
PubMed Close
,
Patricia L M Dahia Dept Medicine, Mays Cancer Center, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA

Search for other papers by Patricia L M Dahia in
Google Scholar
PubMed Close
,
Emilie Ait-Yahya CHU Lille, Institut de Biochimie & Biologie Moléculaire, Centre de Biologie Pathologie Génétique, Lille, France

Search for other papers by Emilie Ait-Yahya in
Google Scholar
PubMed Close
,
Michel Crépin CHU Lille, Service de Biochimie Hormonologie, Métabolisme, Nutrition-Oncologie, Centre de Biologie Pathologie Génétique, Lille, France

Search for other papers by Michel Crépin in
Google Scholar
PubMed Close
, and
Pascal Pigny CHU Lille, Service de Biochimie Hormonologie, Métabolisme, Nutrition-Oncologie, Centre de Biologie Pathologie Génétique, Lille, France

Search for other papers by Pascal Pigny in
Google Scholar
PubMed Close

leiomyosarcoma were removed. Her paternal grandfather (I-1) had bilateral PCC at 70 years and her father (II-2) had a lung adenocarcinoma at 47 years and prostatic cancer at 54 years. The proband’s youngest brother (III-3) presented at 31 years with a

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-20-0460
Volume/Issue:
Volume 9: Issue 10
Open access
Ruth Percik Institute of Endocrinology, Diabetes and Metabolism, Sheba Medical Centre, Ramat Gan, Israel

Search for other papers by Ruth Percik in
Google Scholar
PubMed Close
,
Sherwin Criseno Department of Endocrinology, University Hospital Birmingham, Birmingham, UK

Search for other papers by Sherwin Criseno in
Google Scholar
PubMed Close
,
Safwaan Adam Department of Endocrinology, The Christie NHS Foundation Trust, Manchester, UK

Search for other papers by Safwaan Adam in
Google Scholar
PubMed Close
,
Kate Young Royal Marsden Hospital, London, UK

Search for other papers by Kate Young in
Google Scholar
PubMed Close
, and
Daniel L Morganstein Department of Endocrinology, Chelsea and Westminster Hospital, London, UK
Royal Marsden Hospital, London, UK

Search for other papers by Daniel L Morganstein in
Google Scholar
PubMed Close

|Effects of immunotherapy (finding)| This term should be used in all individuals with an endocrine adverse event from cancer immunotherapy. This will enable case finding of endocrine IRAEs whilst allowing the use of standardised endocrine terminology

Article Type:
Review Article
Collections:
Hormones and Cancer
DOI:
https://doi.org/10.1530/EC-22-0513
Volume/Issue:
Volume 12: Issue 5
Open access